{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:30:35Z","timestamp":1793727035754,"version":"4.6.1"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Bone and joint infections (BJIs) are a significant clinical challenge due to their tendency to recur, increased healthcare expenses, reduced quality of life, and mortality. Patients with BJIs are a heterogeneous group due to their different clinical presentations as well as patient-related risk factors. Empiric antibiotic regimens are commonly based on deductions from in vitro microbiologic findings, despite the fact that their relative efficacy and optimal antibiotic choices are underexplored. Methods: This retrospective cohort study included 521 patients surgically treated for BJIs at a specialized orthopedic infection unit between 2016 and 2023. Treatment strategies were guided by the Oral Versus Intravenous Antibiotics for Bone and Joint Infection (OVIVA) trial. All patients received a narrow-spectrum Gram-positive\u2013targeted empiric systemic antibiotic regimen determined according to regional recommendations in collaboration with infectious disease specialists. The primary outcome was clinical failure within one year, with a minimum follow-up of 12 months. For the analyses, the patients were divided into three groups based on microbiological susceptibility: susceptible (SusEmp), non-susceptible (NonSus) and culture-negative (CulNeg) patients. Results: The three groups were found to differ significantly in seven patient-related factors: sex, age at primary operation (OP age), BMI, ASA group, diabetes status, peripheral arterial disease status (PAD), and endocrinopathy status (other than diabetes). In performing multivariate analyses, OP age was found to be independently associated with the overall failure rate (p = 0.04) and ASA group (p = 0.047), and PAD (p = 0.043) was independently associated with the secondary outcome of proximal amputation. Patients with non-susceptible pathogens (NonSus) had more than twice the odds of clinical failure (OR: 2.10; 95% CI: 1.12\u20133.95) and nearly fivefold higher odds of secondary proximal amputation (OR: 4.95; 95% CI: 1.41\u201323.2) compared with patients with susceptible pathogens (SusEmp). Conclusions: The current study demonstrates that a large group of patients can presumably be treated safely with a more restrictive narrow approach. More studies are needed to identify subgroups suited for the safe use of a narrow-spectrum empiric regimen, hereby reserving the broad-spectrum antibiotics for patients with the right indications and for whom it would have a positive effect on the clinical outcome. Such an approach would justify a more restrictive stewardship of broad-spectrum antibiotic use without negatively impacting patient outcomes.<\/jats:p>","DOI":"10.3390\/antibiotics15060620","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:59:38Z","timestamp":1781773178000},"page":"620","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Narrow Empiric Antibiotic Spectrum and Patient Characteristics on Clinical Outcomes in Bone and Joint Infections: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6251-3042","authenticated-orcid":false,"given":"Lasse B\u00e6k","family":"Krag","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Horsens Hospital, 8700 Horsens, Denmark"},{"name":"Department of Orthopedic Surgery, Herlev Hospital, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-2903","authenticated-orcid":false,"given":"Anton Alexander Nolte","family":"Peterlin","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Herlev Hospital, 2730 Herlev, Denmark"},{"name":"Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1536-2029","authenticated-orcid":false,"given":"Emil","family":"Gleipner-Andersen","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Herlev Hospital, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-8392","authenticated-orcid":false,"given":"Hans","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Herlev Hospital, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1530\/EOR-23-0078","article-title":"Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection","volume":"8","author":"Xu","year":"2023","journal-title":"EFORT Open Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jor.25765","article-title":"2023 International Consensus Meeting on musculoskeletal infection: Summary from the treatment workgroup and consensus on treatment in preclinical models","volume":"42","author":"Jennings","year":"2024","journal-title":"J. Orthop. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5194\/jbji-6-257-2021","article-title":"Systematic review of risk prediction studies in bone and joint infection: Are modifiable prognostic factors useful in predicting recurrence?","volume":"6","author":"Dudareva","year":"2021","journal-title":"J. Bone Jt. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/BOT.0000000000001626","article-title":"Recommendations for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus from an International Expert Group","volume":"34","author":"Depypere","year":"2020","journal-title":"J. Orthop. Trauma"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-1381.R1","article-title":"The EBJIS definition of periprosthetic joint infection","volume":"103-B","author":"McNally","year":"2021","journal-title":"Bone Jt. J."},{"key":"ref_6","unstructured":"European Centre for Disease Prevention and Control (2024, November 17). Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2023-2021-data."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/17425255.2022.2117607","article-title":"The mysteries of target site concentrations of antibiotics in bone and joint infections: What is known? A narrative review","volume":"18","author":"Koch","year":"2022","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcpa.2017.10.001","article-title":"Suppurative Inflammation and Local Tissue Destruction Reduce the Penetration of Cefuroxime to Infected Bone Implant Cavities","volume":"157","author":"Jensen","year":"2017","journal-title":"J. Comp. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e0002423","DOI":"10.1128\/cmr.00024-23","article-title":"Biofilm antimicrobial susceptibility testing: Where are we and where could we be going?","volume":"36","author":"Coenye","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.injury.2017.08.040","article-title":"Fracture-related infection: A consensus on definition from an international expert group","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Besal, R., Adami\u010d, P., Beovi\u0107, B., and Papst, L. (2023). Systemic Antimicrobial Treatment of Chronic Osteomyelitis in Adults: A Narrative Review. Antibiotics, 12.","DOI":"10.3390\/antibiotics12060944"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00068-019-01182-6","article-title":"The effect of early broad-spectrum versus delayed narrow-spectrum antibiotic therapy on the primary cure rate of acute infection after osteosynthesis","volume":"46","author":"Hellebrekers","year":"2020","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rupp, M., Baertl, S., Walter, N., Hitzenbichler, F., Ehrenschwender, M., and Alt, V. (2021). Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10080921"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Baertl, S., Walter, N., Engelstaedter, U., Ehrenschwender, M., Hitzenbichler, F., Alt, V., and Rupp, M. (2022). What Is the Most Effective Empirical Antibiotic Treatment for Early, Delayed, and Late Fracture-Related Infections?. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030287"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Poudel, A.N., Zhu, S., Cooper, N., Little, P., Tarrant, C., Hickman, M., and Yao, G. (2023). The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0285170"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S1473-3099(23)00503-0","article-title":"The global burden of fracture-related infection: Can we do better?","volume":"24","author":"Metsemakers","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.cmi.2016.01.004","article-title":"Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study","volume":"22","author":"Frei","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","first-page":"Cd004439","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"2013","author":"Conterno","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1302\/2046-3758.146.BJR-2024-0410.R1","article-title":"Detection limitations of bacteria in tissue samples","volume":"14","author":"Jakobsen","year":"2025","journal-title":"Bone Jt. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1111\/dom.15228","article-title":"Initial antibiotic therapy for postoperative moderate or severe diabetic foot infections: Broad versus narrow spectrum, empirical versus targeted","volume":"25","author":"Nieuwland","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5194\/jbji-10-285-2025","article-title":"Inadequate empirical antibiotics following debridement for orthopedic infections do not increase therapy failures","volume":"10","author":"Maurer","year":"2025","journal-title":"J. Bone Jt. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e0014323","DOI":"10.1128\/cmr.00143-23","article-title":"Anaerobes in diabetic foot infections: Pathophysiology, epidemiology, virulence, and management","volume":"37","author":"Villa","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5194\/jbji-6-151-2021","article-title":"A retrospective cohort study comparing clinical outcomes and healthcare resource utilisation in patients undergoing surgery for osteomyelitis in England: A case for reorganising orthopaedic infection services","volume":"6","author":"Ferguson","year":"2021","journal-title":"J. Bone Jt. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7150\/jbji.17234","article-title":"Ceramic Biocomposites as Biodegradable Antibiotic Carriers in the Treatment of Bone Infections","volume":"2","author":"Ferguson","year":"2017","journal-title":"J. Bone Jt. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1302\/2046-3758.77.BJR-2018-0043.R1","article-title":"The effect of local antibiotic prophylaxis when treating open limb fractures: A systematic review and meta-analysis","volume":"7","author":"Morgenstern","year":"2018","journal-title":"Bone Jt. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lourtet-Hasco\u00ebt, J., Bonnet, E., Spera, A.M., Ascione, T., Chan, M., Esposito, S., Pagliano, P., Scobie, A., \u00dcnal, S., and Giordano, G. (2025). Fracture-Related Infections: Current Status and Perspectives from the International Society of Antimicrobial Chemotherapy. Antibiotics, 14.","DOI":"10.3390\/antibiotics14111095"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Steadman, W., Chapman, P.R., Schuetz, M., Schmutz, B., Trampuz, A., and Tetsworth, K. (2023). Local Antibiotic Delivery Options in Prosthetic Joint Infection. Antibiotics, 12.","DOI":"10.3390\/antibiotics12040752"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112837","DOI":"10.1016\/j.injury.2025.112837","article-title":"Gram-negative and Gram-positive bacteria induce different osteolysis progression profiles over time in fracture-related infections","volume":"56","author":"Peterlin","year":"2025","journal-title":"Injury"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3928\/01477447-20220105-04","article-title":"Risk Factors for Gram-Negative Fracture-Related Infection","volume":"45","author":"Konda","year":"2022","journal-title":"Orthopedics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ofac297","DOI":"10.1093\/ofid\/ofac297","article-title":"Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients with Diabetic Foot Infections","volume":"9","author":"Veve","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yan, X., Song, J.-f., Zhang, L., and Li, X. (2022). Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00957-0"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3310\/hta23380","article-title":"Oral versus intravenous antibiotics for bone and joint infections: The OVIVA non-inferiority RCT","volume":"23","author":"Scarborough","year":"2019","journal-title":"Health Technol. Assess."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5194\/jbji-10-199-2025","article-title":"CLOSE-UP\u2014A favourable protocol for limb-sparing surgery of diabetic foot osteomyelitis","volume":"10","author":"Peterlin","year":"2025","journal-title":"J. Bone Jt. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOT.0000000000001614","article-title":"Diagnosing Fracture-Related Infection: Current Concepts and Recommendations","volume":"34","author":"Govaert","year":"2020","journal-title":"J. Orthop. Trauma"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Peterlin, A.A.N., McNally, M., Henriksen, N.L., Blirup-Plum, S.A., J\u00f8rgensen, A., J\u00f8rgensen, A.I., Brock, I., Gottlieb, H., and Jensen, L.K. (2025). Exploring the Value of Paired Microbiology and Histology in Chronic Osteomyelitis and Fracture-Related Infections. Antibiotics, 14.","DOI":"10.3390\/antibiotics14121277"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1302\/0301-620X.104B9.BJJ-2022-0396.R1","article-title":"Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier","volume":"104-B","author":"McNally","year":"2022","journal-title":"Bone Jt. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2106\/JBJS.20.00409","article-title":"Providing an Evidence Base for Tissue Sampling and Culture Interpretation in Suspected Fracture-Related Infection","volume":"103","author":"Dudareva","year":"2021","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.injury.2016.09.019","article-title":"Infection after fracture fixation: Current surgical and microbiological concepts","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus Intravenous Antibiotics for Bone and Joint Infection","volume":"380","author":"Li","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/620\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:44:21Z","timestamp":1781775861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["antibiotics15060620"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15060620","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}